chr6-129297646-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000426.4(LAMA2):​c.2857-39T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0142 in 1,598,178 control chromosomes in the GnomAD database, including 205 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.010 ( 11 hom., cov: 33)
Exomes 𝑓: 0.015 ( 194 hom. )

Consequence

LAMA2
NM_000426.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.667

Publications

1 publications found
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
  • congenital merosin-deficient muscular dystrophy 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • LAMA2-related muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy, limb-girdle, autosomal recessive 23
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 3 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 6-129297646-T-C is Benign according to our data. Variant chr6-129297646-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 256062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0103 (1565/152310) while in subpopulation NFE AF = 0.0163 (1112/68014). AF 95% confidence interval is 0.0156. There are 11 homozygotes in GnomAd4. There are 727 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA2NM_000426.4 linkc.2857-39T>C intron_variant Intron 20 of 64 ENST00000421865.3 NP_000417.3
LAMA2NM_001079823.2 linkc.2857-39T>C intron_variant Intron 20 of 63 NP_001073291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA2ENST00000421865.3 linkc.2857-39T>C intron_variant Intron 20 of 64 5 NM_000426.4 ENSP00000400365.2 P24043
LAMA2ENST00000618192.5 linkc.3121-39T>C intron_variant Intron 21 of 65 5 ENSP00000480802.2 A0A087WX80
LAMA2ENST00000617695.5 linkc.2857-39T>C intron_variant Intron 20 of 63 5 ENSP00000481744.2 A0A087WYF1

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1562
AN:
152192
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00359
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00818
Gnomad ASJ
AF:
0.00750
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0101
Gnomad FIN
AF:
0.00781
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0163
Gnomad OTH
AF:
0.00764
GnomAD2 exomes
AF:
0.0108
AC:
2704
AN:
249598
AF XY:
0.0110
show subpopulations
Gnomad AFR exome
AF:
0.00298
Gnomad AMR exome
AF:
0.00501
Gnomad ASJ exome
AF:
0.00886
Gnomad EAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.00896
Gnomad NFE exome
AF:
0.0163
Gnomad OTH exome
AF:
0.0140
GnomAD4 exome
AF:
0.0146
AC:
21128
AN:
1445868
Hom.:
194
Cov.:
29
AF XY:
0.0146
AC XY:
10517
AN XY:
720248
show subpopulations
African (AFR)
AF:
0.00248
AC:
82
AN:
33124
American (AMR)
AF:
0.00557
AC:
248
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
0.00829
AC:
216
AN:
26040
East Asian (EAS)
AF:
0.0000757
AC:
3
AN:
39622
South Asian (SAS)
AF:
0.0101
AC:
869
AN:
85792
European-Finnish (FIN)
AF:
0.00947
AC:
505
AN:
53302
Middle Eastern (MID)
AF:
0.0102
AC:
44
AN:
4326
European-Non Finnish (NFE)
AF:
0.0167
AC:
18349
AN:
1099380
Other (OTH)
AF:
0.0136
AC:
812
AN:
59740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1100
2199
3299
4398
5498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0103
AC:
1565
AN:
152310
Hom.:
11
Cov.:
33
AF XY:
0.00976
AC XY:
727
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00358
AC:
149
AN:
41576
American (AMR)
AF:
0.00817
AC:
125
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00750
AC:
26
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.0108
AC:
52
AN:
4830
European-Finnish (FIN)
AF:
0.00781
AC:
83
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0163
AC:
1112
AN:
68014
Other (OTH)
AF:
0.00756
AC:
16
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
83
167
250
334
417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0139
Hom.:
24
Bravo
AF:
0.00938
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 11, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
5.9
DANN
Benign
0.65
PhyloP100
0.67
BranchPoint Hunter
3.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117096733; hg19: chr6-129618791; API